By vgreene, 25 April, 2020 FDA MedWatch: Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems; see FDA alert
By vgreene, 24 April, 2020 Plan for a surge of critically ill pts and identify additional space to care for these pts. Use alternate/separate spaces in ER, ICUs, and other pt care areas to manage known/suspected COVID-19 pts. Separate known/ suspected COVID-19 pts from other pts (“
By vgreene, 24 April, 2020 Shift elective urgent in-pt diagnostic and surgical procedures to out-pt settings, when feasible
By vgreene, 24 April, 2020 Eliminate pt penalties for cancellations and missed appointments related to respiratory illness
By vgreene, 24 April, 2020 Ask symptomatic pts who need to be seen in clinical setting to call before they leave home, so staff are ready to receive them using appropriate infxn control practices and PPE